comparemela.com

Latest Breaking News On - Blueprint medicines corp - Page 3 : comparemela.com

S&P 500 Futures Decline in Premarket Trading; agilon health, Palantir Technologies Lag

Cogent Biosciences stock drops as analysts see tough competition for mastocytosis treatment

Director Jeffrey Albers Sells 10,000 Shares of Blueprint Medicines Corp

On November 3, 2023, Jeffrey Albers, a director at Blueprint Medicines Corp (NASDAQ:BPMC), sold 10,000 shares of the company's stock.

Three stocks positioned for growth in the biotech sector: analyst

Three stocks positioned for growth in the biotech sector: analyst
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.